These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34032997)

  • 1. SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?
    Haq M; Rehman A; Ahmad J; Zafar U; Ahmed S; Khan MA; Naveed A; Rajab H; Muhammad F; Naushad W; Aman M; Rehman HU; Ahmad S; Anwar S; Haq NU
    Infection; 2021 Oct; 49(5):983-988. PubMed ID: 34032997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19.
    Zaidi S; Rizwan F; Riaz Q; Siddiqui A; Khawaja S; Imam M; Naz A; Waheed S; Shamsi T
    J Public Health (Oxf); 2021 Apr; 43(1):3-8. PubMed ID: 32940328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 herd immunity of the Kyrgyz population in 2021.
    Popova AY; Kasymov OT; Smolenski VY; Smirnov VS; Egorova SA; Nurmatov ZS; Milichkina AM; Suranbaeva GS; Kuchuk TE; Khamitova IV; Zueva EV; Ivanov VA; Nuridinova ZN; Derkenbaeva AA; Drobyshevskaya VG; Sattarova GZ; Kaliev MT; Gubanova AV; Zhimbaeva OB; Razumovskaya AP; Verbov VN; Likhachev IV; Krasnov AV; Totolian AA
    Med Microbiol Immunol; 2022 Aug; 211(4):195-210. PubMed ID: 35780233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study.
    Nah EH; Cho S; Park H; Hwang I; Cho HI
    BMJ Open; 2021 Apr; 11(4):e049837. PubMed ID: 33895722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!
    Núñez-Zapata SF; Benites-Peralta B; Mayta-Tristan P; Rodríguez-Morales AJ
    Int J Infect Dis; 2021 Aug; 109():244-246. PubMed ID: 34260956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based seroprevalence of SARS-CoV-2 and the herd immunity threshold in Maranhão.
    Silva AAMD; Lima-Neto LG; Azevedo CMPES; Costa LMMD; Bragança MLBM; Barros Filho AKD; Wittlin BB; Souza BF; Oliveira BLCA; Carvalho CA; Thomaz EBAF; Simões-Neto EA; Leite Júnior JF; Cosme LMSS; Campos MAG; Queiroz RCS; Costa SS; Carvalho VA; Simões VMF; Alves MTSSBE; Santos AMD
    Rev Saude Publica; 2020; 54():131. PubMed ID: 33331525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina.
    Halili R; Bunjaku J; Gashi B; Hoxha T; Kamberi A; Hoti N; Agahi R; Basha V; Berisha V; Hoxha I
    BMC Infect Dis; 2022 Jan; 22(1):57. PubMed ID: 35034617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 seroprevalence in Pakistan: a cross-sectional study.
    Ahmad AM; Shahzad K; Masood M; Umar M; Abbasi F; Hafeez A
    BMJ Open; 2022 Apr; 12(4):e055381. PubMed ID: 35387815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.
    Angulo FJ; Finelli L; Swerdlow DL
    JAMA Netw Open; 2021 Jan; 4(1):e2033706. PubMed ID: 33399860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of SARS-CoV-2 antibodies in the general population of Oman: results from four successive nationwide sero-epidemiological surveys.
    Al-Abri SS; Al-Wahaibi A; Al-Kindi H; Kurup PJ; Al-Maqbali A; Al-Mayahi Z; Al-Tobi MH; Al-Katheri SH; Albusaidi S; Al-Sukaiti MH; Al Balushi AYM; Abdelgadir IO; Al-Shehi N; Morkos E; Al-Maani A; Al-Rawahi B; Alyaquobi F; Alqayoudhi A; Al-Harthy K; Al-Khalili S; Al-Rashdi A; Al-Shukri I; Al Ghafri TS; Al-Hashmi F; Al Jassasi SM; Alshaqsi N; Mitra N; Al Aamry HS; Shah P; Al Marbouai HH; Al Araimi AH; Kair IM; Al Manji AM; Almallak AS; Al Alawi FK; Vaidya V; Muqeetullah M; Alrashdi H; Al Jamoudi SSN; Alshaqsi A; Al Sharji A; Al Shukeiri H; Al-Abri B; Al-Rawahi S; Al-Lamki SH; Al-Manji A; Al-Jardani A
    Int J Infect Dis; 2021 Nov; 112():269-277. PubMed ID: 34601146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.
    Beaumont A; Durand C; Ledrans M; Schwoebel V; Noel H; Le Strat Y; Diulius D; Colombain L; Médus M; Gueudet P; Mouly D; Aumaître H
    BMJ Open; 2021 Nov; 11(11):e053201. PubMed ID: 34815286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
    Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
    Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
    Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis.
    Chisale MRO; Ramazanu S; Mwale SE; Kumwenda P; Chipeta M; Kaminga AC; Nkhata O; Nyambalo B; Chavura E; Mbakaya BC
    Rev Med Virol; 2022 Mar; 32(2):e2271. PubMed ID: 34228851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study.
    Zamani M; Poustchi H; Mohammadi Z; Dalvand S; Sharafkhah M; Motevalian SA; Eslami S; Emami A; Somi MH; Yazdani-Charati J; Saki N; Karami M; Najafi F; Mohebbi I; Veisi N; Hormati A; Pourfarzi F; Ghadimi R; Ansari-Moghaddam A; Sharifi H; Roshandel G; Mansour-Ghanaei F; Joukar F; Shayanrad A; Eghtesad S; Niavarani A; Delavari A; Kaveh S; Feizesani A; Markarian M; Shafighian F; Sadjadi A; Darvishian M; Malekzadeh R
    BMC Public Health; 2022 May; 22(1):1031. PubMed ID: 35606743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey.
    Hoballah A; El Haidari R; Siblany G; Abdel Sater F; Mansour S; Hassan H; Abou-Abbas L
    BMC Infect Dis; 2022 Jan; 22(1):42. PubMed ID: 35012464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-Based Seroprevalence of SARS-CoV-2 Antibodies following the First Wave of the COVID-19 Pandemic in Jazan Province, Saudi Arabia.
    Alhazmi A; Alamer E; Abdelwahab S; Khamjan N; Hamami A; Haddad M; Darraj M; Hashem AM; Algaissi A
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.
    Davila-Siliezar P; Wer A; Barnoya J
    Ann Med; 2021 Dec; 53(1):1956-1959. PubMed ID: 34727801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.